The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Post Herpetic Neuralgia Therapies Market Research Report 2025
Synopsis
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
The global Post Herpetic Neuralgia Therapies market was valued at US$ 1586 million in 2023 and is anticipated to reach US$ 2084.2 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Post Herpetic Neuralgia Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post Herpetic Neuralgia Therapies.
Report Scope
The Post Herpetic Neuralgia Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post Herpetic Neuralgia Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post Herpetic Neuralgia Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Segment by Type
Drugs
Patches
Steroid Injectable
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post Herpetic Neuralgia Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
The global Post Herpetic Neuralgia Therapies market was valued at US$ 1586 million in 2023 and is anticipated to reach US$ 2084.2 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Post Herpetic Neuralgia Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post Herpetic Neuralgia Therapies.
Report Scope
The Post Herpetic Neuralgia Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Post Herpetic Neuralgia Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post Herpetic Neuralgia Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Segment by Type
Drugs
Patches
Steroid Injectable
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post Herpetic Neuralgia Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drugs
1.2.3 Patches
1.2.4 Steroid Injectable
1.3 Market by Application
1.3.1 Global Post Herpetic Neuralgia Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post Herpetic Neuralgia Therapies Market Perspective (2019-2030)
2.2 Post Herpetic Neuralgia Therapies Growth Trends by Region
2.2.1 Global Post Herpetic Neuralgia Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Post Herpetic Neuralgia Therapies Historic Market Size by Region (2019-2024)
2.2.3 Post Herpetic Neuralgia Therapies Forecasted Market Size by Region (2025-2030)
2.3 Post Herpetic Neuralgia Therapies Market Dynamics
2.3.1 Post Herpetic Neuralgia Therapies Industry Trends
2.3.2 Post Herpetic Neuralgia Therapies Market Drivers
2.3.3 Post Herpetic Neuralgia Therapies Market Challenges
2.3.4 Post Herpetic Neuralgia Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue
3.1.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue (2019-2024)
3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue
3.4 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio
3.4.1 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Therapies Revenue in 2023
3.5 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served
3.6 Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
3.7 Date of Enter into Post Herpetic Neuralgia Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post Herpetic Neuralgia Therapies Breakdown Data by Type
4.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Type (2019-2024)
4.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2025-2030)
5 Post Herpetic Neuralgia Therapies Breakdown Data by Application
5.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Application (2019-2024)
5.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Post Herpetic Neuralgia Therapies Market Size (2019-2030)
6.2 North America Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024)
6.4 North America Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post Herpetic Neuralgia Therapies Market Size (2019-2030)
7.2 Europe Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024)
7.4 Europe Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size (2019-2030)
8.2 Asia-Pacific Post Herpetic Neuralgia Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post Herpetic Neuralgia Therapies Market Size (2019-2030)
9.2 Latin America Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024)
9.4 Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size (2019-2030)
10.2 Middle East & Africa Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Endo Pharmaceuticals
11.1.1 Endo Pharmaceuticals Company Detail
11.1.2 Endo Pharmaceuticals Business Overview
11.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Introduction
11.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.1.5 Endo Pharmaceuticals Recent Development
11.2 Depomed
11.2.1 Depomed Company Detail
11.2.2 Depomed Business Overview
11.2.3 Depomed Post Herpetic Neuralgia Therapies Introduction
11.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.2.5 Depomed Recent Development
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Detail
11.3.2 Acorda Therapeutics Business Overview
11.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Introduction
11.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.3.5 Acorda Therapeutics Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Post Herpetic Neuralgia Therapies Introduction
11.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Post Herpetic Neuralgia Therapies Introduction
11.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.5.5 Mylan Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Detail
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Introduction
11.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.6.5 Daiichi Sankyo Recent Development
11.7 Teikoku Pharma
11.7.1 Teikoku Pharma Company Detail
11.7.2 Teikoku Pharma Business Overview
11.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Introduction
11.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024)
11.7.5 Teikoku Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drugs
Table 3. Key Players of Patches
Table 4. Key Players of Steroid Injectable
Table 5. Global Post Herpetic Neuralgia Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Post Herpetic Neuralgia Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Post Herpetic Neuralgia Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Post Herpetic Neuralgia Therapies Market Share by Region (2019-2024)
Table 9. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Post Herpetic Neuralgia Therapies Market Share by Region (2025-2030)
Table 11. Post Herpetic Neuralgia Therapies Market Trends
Table 12. Post Herpetic Neuralgia Therapies Market Drivers
Table 13. Post Herpetic Neuralgia Therapies Market Challenges
Table 14. Post Herpetic Neuralgia Therapies Market Restraints
Table 15. Global Post Herpetic Neuralgia Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Post Herpetic Neuralgia Therapies Market Share by Players (2019-2024)
Table 17. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2023)
Table 18. Ranking of Global Top Post Herpetic Neuralgia Therapies Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Post Herpetic Neuralgia Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
Table 22. Date of Enter into Post Herpetic Neuralgia Therapies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post Herpetic Neuralgia Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2019-2024)
Table 26. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2025-2030)
Table 28. Global Post Herpetic Neuralgia Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2019-2024)
Table 30. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2025-2030)
Table 32. North America Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 47. Endo Pharmaceuticals Company Detail
Table 48. Endo Pharmaceuticals Business Overview
Table 49. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product
Table 50. Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 51. Endo Pharmaceuticals Recent Development
Table 52. Depomed Company Detail
Table 53. Depomed Business Overview
Table 54. Depomed Post Herpetic Neuralgia Therapies Product
Table 55. Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 56. Depomed Recent Development
Table 57. Acorda Therapeutics Company Detail
Table 58. Acorda Therapeutics Business Overview
Table 59. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product
Table 60. Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 61. Acorda Therapeutics Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Post Herpetic Neuralgia Therapies Product
Table 65. Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Mylan Company Detail
Table 68. Mylan Business Overview
Table 69. Mylan Post Herpetic Neuralgia Therapies Product
Table 70. Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 71. Mylan Recent Development
Table 72. Daiichi Sankyo Company Detail
Table 73. Daiichi Sankyo Business Overview
Table 74. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product
Table 75. Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 76. Daiichi Sankyo Recent Development
Table 77. Teikoku Pharma Company Detail
Table 78. Teikoku Pharma Business Overview
Table 79. Teikoku Pharma Post Herpetic Neuralgia Therapies Product
Table 80. Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2019-2024) & (US$ Million)
Table 81. Teikoku Pharma Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post Herpetic Neuralgia Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Post Herpetic Neuralgia Therapies Market Share by Type: 2023 VS 2030
Figure 3. Drugs Features
Figure 4. Patches Features
Figure 5. Steroid Injectable Features
Figure 6. Global Post Herpetic Neuralgia Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Post Herpetic Neuralgia Therapies Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 12. Global Post Herpetic Neuralgia Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Post Herpetic Neuralgia Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Post Herpetic Neuralgia Therapies Market Share by Region: 2023 VS 2030
Figure 15. Global Post Herpetic Neuralgia Therapies Market Share by Players in 2023
Figure 16. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Post Herpetic Neuralgia Therapies Revenue in 2023
Figure 18. North America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Post Herpetic Neuralgia Therapies Market Share by Country (2019-2030)
Figure 20. United States Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Post Herpetic Neuralgia Therapies Market Share by Country (2019-2030)
Figure 24. Germany Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Post Herpetic Neuralgia Therapies Market Share by Region (2019-2030)
Figure 32. China Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Post Herpetic Neuralgia Therapies Market Share by Country (2019-2030)
Figure 40. Mexico Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Post Herpetic Neuralgia Therapies Market Share by Country (2019-2030)
Figure 44. Turkey Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Endo Pharmaceuticals Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 47. Depomed Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 48. Acorda Therapeutics Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 50. Mylan Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 51. Daiichi Sankyo Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 52. Teikoku Pharma Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
